Results at 30 June 2013
|
|
- Adela Ray
- 6 years ago
- Views:
Transcription
1 Results at 30 June September half-year earnings
2 INTERVENANTS Yann Coléou Directeur général Louis Guyot Directeur général finances Philippe Denormandie Directeur général adjoint half-year earnings
3 SPEAKERS Yann Coléou CEO Louis Guyot CFO Philippe Denormandie Deputy CEO half-year earnings
4 Key events EVENTS OBJECTIVES Successful friendly takeover of Curanum Leader in 3 countries Sale of psychiatric division on good terms Refocusing on our core businesses Strong improvement in performance and reinforced financial structure Now among the best in the sector half-year earnings
5 The Korian corporate project To take the lead and become the No.1 player in the Healthy Ageing market A corporate project based on four pillars half-year earnings
6 1 PERFORMANCE 2 DEVELOPMENT 3 INNOVATION 4 OUR PEOPLE, OUR TEAMS half-year earnings
7 1 PERFORMANCE half-year earnings 2013 half-year earnings 7
8 Significant increase in earnings % In millions +21.0% +32.6% In millions Current net income (Grp share) (2) up +65.9% Margin rate % of revenues % 26.1 % %12.2 % x x3.0 x Restated leverage (3) June 2012 June 2013 June 2012 June 2013 June 2012 June 2013 June 2012 June 2013 Dec 2011 Dec 2012 June 2013 Revenues EBITDAR (1) EBITDA Net income (Group share) Net debt 21% growth Margin up by 230 bp (1) EBITDAR is the interim management balance sheet measurement preferred by the Korian Group to monitor the operational performance of its facilities. It consists of gross operating surplus of the operating sectors before leasing expenses. (2) Current net income (Group share) represents net income (Group share) - (other operating income and expenses + gains and losses on acquisitions and disposals of subsidiaries) x (1 - standard corporate income tax of 35%), or restated net income (Group share) for non-recurring items. (3) (Net debt Real estate debt) / (EBITDA 7%* Real estate debt) half-year earnings
9 Strong dynamic in Germany Solid organic growth France: +3.2% In millions Growth: +21.0% Organic growth: + 3.5% , June 2012 France + 3.2% % Germany % June 2013 Italy Of which organic growth + 4.2% + 6.4% - 1.6% Robust organic growth +4.2% - Good occupancy rate: 95.8% in mature facilities - Improved management of pricing, especially in follow-up care and rehabilitation (SSR) Two nursing homes sold in late 2012 Germany: % Curanum consolidated since 1 March 2013 Organic growth increases to 6.4% with the achievement of full occupancy in 2011 / 2012 Average occupancy rate 93.0% in the mature segment Italy: -1.6% High average occupancy in the mature segment: 96.9% Acceleration of restructuring, and base effect half-year earnings
10 INTERVENANTS Yann Coléou Directeur général Louis Guyot Directeur général finances Philippe Denormandie Directeur général adjoint half-year earnings
11 Strong growth in margins in all countries In millions Consolidated France Germany Italy June 2013 / June 2012 June 2013 / June 2012 June 2013 / June 2012 June 2013 / June 2012 Revenue EBITDAR % of revenue 26.1% 23.8% 25.9% 24.1% 28.1% 24.3% 22.9% 22.2% Change in margins +230 bp +180 bp +380 bp +70 bp half-year earnings
12 EBITDA up as a result of optimum cost control In millions 30/06/ /06/2012 Change Revenue % Staff costs % of revenue Other external purchases and expenses Taxes (319.4) 48.2% (148.3) (22.6) (265.0) 48.4% (131.6) (21.0) 20.5% 12.7% 7.4% EBITDAR % External rents % of revenue 26.1% % % Strong cost control Like-for-like growth in rents limited to 2% EBITDA % % of revenue 12.2% 11.4% half-year earnings
13 Improvement in net earnings 30/06/ /06/2012 Change In millions EBITDA (1) % Depreciation and provisions (28.0) (22.8) EBIT Non-recurring items (2) Operating income (4.3) (2.0) % 33.7% 120.6% 29.2% Financial income Income before taxes Income tax % income before taxes Net income (Group share) Net current inc (Group share) (3) (21.1) (16.7) 26.5% % (9.6) (9.5) 0.6% 34.6% 45.2% % % (1) EBITDA is equivalent to EBITDAR as defined above, less rental expenses. (2) Non-recurring items mainly consist of Curanum acquisition costs ( 4 million). (3) Current net income (Group share) represents net income (Group share) - (other operating income and expenses + gains and losses on acquisitions and disposals of subsidiaries) x (1 - standard corporate income tax of 35%), or restated net income (Group share) for non-recurring items half-year earnings
14 Significant financial room for manoeuvre Net debt trends Leverage unchanged x 3.1x 3.0x Net debt - Real estate debt EBITDA - 7% Real estate debt Default covenant at 5.0x = 3.0x Net debt in million December 2011 December 2012 June Continuing diversification of debt with the issue of a private placement of 67.5 million in August million in available credit lines Average cost of debt: 4.4% Syndicated credit Bonds Other debts Cash (34) (158) (44) half-year earnings
15 2 DEVELOPMENT half-year earnings 2013 half-year earnings 15
16 INTERVENANTS Yann Coléou Directeur général Louis Guyot Directeur général finances Philippe Denormandie Directeur général adjoint half-year earnings
17 KORIAN, EUROPEAN LEADER IN HEALTHY AGEING 321 facilities in Europe 15,709 beds 270 nursing homes (EHPAD) 51 specialised clinics (follow-up care and rehabilitation / SSR) Beds for over 2,200 people in assisted living facilities Homecare services for 9,000 people f r a n c e 14,095 beds 4,389 beds Geographical extent at 12 September 2013 Including Curanum, nearly 34,000 beds in use 59% of which outside France half-year earnings
18 Curanum consolidation timeline MARCH 2013 Successful takeover of Curanum Korian owns 78% of Curanum Phönix and Curanum are operationally two separate companies Identification of the new organisation 1 September 2013 Contribution of Phönix to Curanum Phönix: wholly-owned subsidiary of Curanum Start of consolidation Single Executive Board Appointments: - Regional Directors - Department Heads Reorganisation of procurement and service providers 2014 Consolidation completed half-year earnings
19 CONFIRMATION OF CURANUM'S BUSINESS PLAN The Phönix contribution to Curanum is key to the success of the business plan. Immediate implementation of synergies - Single management and head office - Revamped regional organisation and tighter local networks: sales, local supervision, recruitment, etc. - Unification of management and IT systems - Centralised single purchasing desk: with rapid gains such as energy-price negotiations. - Resource sharing: use of Curanum's in-house laundry service by all facilities. Expected synergies: 1% of revenues when fully realised, ramping up in half-year earnings
20 Seizing the best development opportunities in Europe Germany Neumarkt opens (133 beds) Hamm opens in late 2013 (80 beds + 18 homecare services beds) Special Care unit opened in Bayreuth (better pricing structure) Agreement signed for creation of an 80-bed nursing home (EHPAD) in Meschede In the medium term, development of a platform for organic growth: The long-term objective is to create 1,000 beds a year half-year earnings
21 Seizing the best development opportunities in Europe France Nursing homes opened in Alençon, relocated in Chapelle Saint Mesmin and reopened in Pouliguen (three in total) Authorisation obtained for 70 follow-up care and rehabilitation (SSR) beds in Troyes Italy Budget clawed back for the (closed) Pergolino clinic in Florence Acquisition of the Munari clinic in Florence: restructuring launched for the four clinics in Tuscany (grouped on two sites) New pricing structure secured for nursing homes in Pouilles and Latium half-year earnings
22 Secure growth of more than 5,000 beds Type of beds Number of beds France Germany Italy Impact type Beds to be constructed and in the process of acquisition 1, Increase in revenue + increase in total facilities Beds constructed and in the process of being filled 349* 86* 199* 64* Increase in revenue Beds to be restructured 3,258 2, ,074 Primarily improved margins Total 5,412 2,958 1,028 1,426 * For facilities that have been ramped up: annual beds constructed * (regulated occupancy rate average occupancy rate) Major inherent potential for strong organic growth A development platform in Germany to deliver 1,000 beds a year half-year earnings
23 3 INNOVATION half-year earnings 2013 half-year earnings 23
24 INTERVENANTS Yann Coléou Directeur général Louis Guyot Directeur général finances Philippe Denormandie Directeur général adjoint half-year earnings
25 Innovation is at the heart of Korian's strategy Two facets to innovation: social and forecasting, with Korian's Institut du Bien Vieillir operational, to boost performance half-year earnings
26 KORIAN FIRST - INNOVATION Driving business innovation: Social research to pre-empt social issues and change attitudes (eg: "What are seniors expectations of Healthy Ageing?") Applied research using our data: academic and industrial partnerships on topics related to public health, epidemiology, etc. Korian research and scientific sharing via the production of educational content (eg: Drug leaflets) half-year earnings
27 KORIAN FIRST - INNOVATION In practice 1 st Committee meeting in July Actions 2013: - Project publications: "The Basics" drugs leaflet - Three scientific articles from work submitted for peer review: training tools, pain medications, changes between 2007 and 2011 in the populations catered for - Partnership research programmes: eg. The effect of play on Alzheimers Next Committee meeting in October: formalisation of the social vector half-year earnings
28 Operational innovation Change in biocleaning technology, achieving four objectives: -Better working conditions: fewer musculoskeletal disorders -Productivity: time saving (4 minutes per room) -Reduction in water and chemicals: 50% saving -Residents safety: floors dry faster, chemicals are not accessible half-year earnings
29 Operational innovation Sharing Best Practices: Guide published with 20 case studies of actual workshop operations, issued at the annual convention and circulated to all directors. Examples of applications: - rapid, cost-effective renovation: 25% saving on small-scale renovations - better adaptation of scheduling patterns: building loyalty among employees - individual care in clinics: personalised follow-up from pre-admission right up to discharge half-year earnings
30 Operational innovation Maximization of returns from special follow-up and rehabilitation (SSR) rooms: sales process development of accommodation in line with rates Gains in 2013 are exceeding our expectations half-year earnings
31 4 OUR PEOPLE, OUR TEAMS half-year earnings 2013 half-year earnings 31
32 Deploying the business plan on the ground Management's commitment to communicating the meaning of Korian First on the ground Organisational models to support change Tools to present and share Korian First half-year earnings
33 A new approach to management Promote employee development: promotion from within Build loyalty Mentoring system Induction pathway fully reviewed and standardised Satisfaction indicators monitored: Kommunity employee opinion survey launched in France with an excellent response rate half-year earnings
34 A new approach to management Improving the response to performance challenges Annual interview focused on all aspects of performance Alignment of objectives Exceptional performance bonus where appropriate Recognising success Ten "K d Or Awards" presented at the annual managers' meeting half-year earnings
35 CONCLUSION 2013 GUIDANCE half-year earnings 2013 half-year earnings 35
36 Revised outlook for SFAF March 2013 SFAF Sept Revenue billion billion 1.3 billion 1.35 billion EBITDAR 24% 25% 26% 27% Restated debt ratio 4x 3x 3x 3x To support the Group's rapid growth: Management strengthened Consistency of governance across all countries half-year earnings
37 Results at 30 June September half-year earnings
38 half-year earnings NOTES
39 Distribution of national markets for nursing homes Public 49 % FRANCE (nursing homes / EHPAD) Top 10 private operators 15% Other private 7% Public 47% ITALY (RSA) Top 6 private operators 5% Other private 13% Germany (Pflegeheime) Public 6% Top 10 private operators 11% Other private 26% NGO 29% NGO 35% NGO 57% Available beds 684, , ,000 Beds/ 1,000 persons aged Korian market share 1.5% 1% 1.5% - The Top 10 operators represent 2/3 of the private sector Source: DREES, Istat, Pflegestatistik - The Top 6 operators represent only 4.6% of the market and 26% of the private sector - Between 1999 and 2007, 71% of beds were created by private operators. Their overall market share has therefore increased considerably. - The Top 10 operators represent 30% of beds in the private sector half-year earnings
40 Structure of daily rates in the nursing homes sector FRANCE Average Korian rate: 129 ITALY 123 GERMANY 91 Social security Medical care 25% Breakdown of rates Breakdown of payments Residents and APA* Dependency 10% Regional Social Security Medical care 50% Medical care 60% Pflegekasse ~50% Residents Individual pricing at entry Accommodation + services 65% Residents Individual pricing Accommodation + services 50% Services 25% Real estate 15% Residents or Social Welfare ~50% Personalised Autonomy Allowance Source: Korian half-year earnings
41 Structure of rates in France Typical financing of the daily rate in France Retirement homes Average Korian rate 129 Healthcare 202 Social Security Residents and APA* Medical care 25% Dependency 10% Care and accommodation Social Security 80%** Residents Individual pricing at entry Accommodation + services 65% Lodging supplement 20 % Patients (supplements billed for additional comforts, e.g. private room) * Personalised Autonomy Allowance * * of which approximately 70% corresponds to the daily price Source: Korian half-year earnings
42 Real estate index trends IRL (housing property reference index): inflation excluding tobacco and rents CCI (Construction Cost Index) Nursing home improvement index half-year earnings
43 Income Statement at 30 June 2013 (including Curanum proforma) In M % Curanum Proforma Revenues % EBTIDAR % % Rev., net of tax 26.1% 23.8% 155.2% 26.2% External rents (91.6) (67.7) 35.4% (100.9) EBTIDA % 85.1 % Rev., net of tax 12.2% 11.4% 7.1% 12.0% Amortisation and depreciation (28.0) (22.8) 22.5% (30.1) EBIT % 55.0 % Rev., net of tax 8.0% 7.3% 10.5% 7.7% Non-recurring items (4.3) (2.0) 120.6% (4.6) Operating income % 50.4 % Rev., net of tax 7.4% 6.9% 6.8% 7.1% Financial income (21.1) (16.7) 26.5% (23.0) Income before taxes % 27.4 Income tax (9.6) (9.5) 0.6% (9.3) % of income before tax 35% 45% -23.4% 34% Net income (Group share) % 16.5 Curr net inc (grp share) % 19.5 (1) EBITDAR is the interim management balance sheet measurement preferred by the Korian Group to monitor the operational performance of its facilities. It consists of gross operating surplus of the operating sectors before leasing expenses. (2) EBITDA is equivalent to EBITDAR as defined above, less rental expenses. (3) EBIT is EBITDA as defined above less depreciation, provisions and impairment. (4) Current net income (Group share) represents net income (Group share) - (other operating income and expenses + gains and losses on acquisitions and disposals of subsidiaries) x (1 - standard corporate income tax of 35%), or restated net income (Group share) for non-recurring items half-year earnings
44 Korian consolidated balance sheet at 30 June 2013 In millions NON-CURRENT ASSETS 30/06/ /12/2012 INTANGIBLE FIXED ASSETS 1, ,324.7 Including Goodwill Including Other intangible fixed assets PROPERTY, PLANT AND EQUIPMENT LONG-TERM FINANCIAL ASSETS SHAREHOLDERS' EQUITY (Group share) 30/06/ /12/2012 Share capital Premiums Reserves and consolidated results Total Shareholders' equity (Group share) Minority interests Total Shareholders' Equity Deferred asset taxes Total non-current assets 2, ,774.5 CURRENT ASSETS Inventory Trade receivables and related accounts Other receivables and current assets Financial asset instruments Cash and cash equivalents Total current assets NON-CURRENT LIABILITIES Provision for retirement Deferred taxes Other provisions Borrowings and financial debts Total non-current liabilities CURRENT LIABILITIES Provisions for less than one year Trade payables and related accounts Other liabilities and adjustment accounts Borrowings for < one year & bank overdrafts Other receivables Total current liabilities , , , Assets held for sale Liabilities held for sale TOTAL ASSETS 2, ,231.9 TOTAL LIABILITIES 2, , half-year earnings
45 Korian Cash Flow Statement at 30 June 2013 In millions 30/06/ /06/2012 Cash flow before cost of net financial debt Change in working capital requirement (37.5) (8.1) Net cash flow generated by the activity Net cash flow from investment activities (69.6) (51.7) Net cash flow (33.8) (7.8) Net cash flow from financing activities (79.8) (4.8) Change in cash (113.5) (12.5) Cash half-year earnings
46 Income Statement at 30 June 2013 FRANCE In millions 30/06/ /06/2012 Change Revenue % Staff costs % of revenue Other external purchases and expenses Taxes % % % (2.4)% 7.2% EBITDAR % External rents % of revenue 25.9 % % % EBITDA % % of revenue 14.4% 12.9% half-year earnings
47 Income Statement at 30 June 2013 GERMANY In millions 30/06/ /06/2012 Change Revenue Staff costs % of revenue Other external purchases and expenses Taxes EBITDAR External rents EBITDA % of revenue % % % % % of revenue 8.1% 3.9% 138.6% 130.5% 117.6% 6.7% 175.7% 133.3% 398.0% half-year earnings
48 Income Statement at 30 June 2013 ITALY In millions 30/06/ /06/2012 Change Revenue % Staff costs % of revenue Other external purchases and expenses Taxes % % % 0.0% 17.6% EBITDAR External rents EBITDA % of revenue % % % of revenue 11.3% 11.4% 1.2% 5.6% -2.9% half-year earnings
49 half-year earnings
KORIAN: 2012 HALF-YEAR EARNINGS
PRESS RELEASE KORIAN: 2012 HALF-YEAR EARNINGS GOOD PERFORMANCES FOR THE FIRST HALF OF THE YEAR Revenues: 547.9 million, +12.8% EBITDA: 62.6 million, +14.8% Current net income (group share): 11.7 million,
More informationSolid 2017 results in line with targets
PRESS RELEASE Paris, 14 March 2018 Solid 2017 results in line with targets 5.0% revenue growth driven by the strong international momentum Continued active development strategy with over 3,150 beds added
More informationCreating the European leader of the elderly care sector NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA
Creating the European leader of the elderly care sector DISCLAIMER Important information This presentation does not constitute and shall not be construed as an offer or the solicitation of an offer to
More informationSolid interim results in line with roadmap
PRESS RELEASE Paris, 13 September 2017 Solid interim results in line with roadmap Revenue up 4.9%, driven by strong growth internationally (+9.4%) Stable operating margin (EBITDA) at 13.5%, compared to
More informationKorian improves its operating performance and speeds up its expansion.
PRESS RELEASE Paris, 16 September 2015 Korian improves its operating performance and speeds up its expansion. Revenue: 1,264 million, in line with Group targets Operating profitability increased to 13.6%
More information2016 FULL-YEAR RESULTS. March 16ᵗʰ, 2017
2016 FULL-YEAR RESULTS March 16ᵗʰ, 2017 2016 OVERVIEW 2016 FULL-YEAR RESULTS March 16ᵗʰ, 2017 2016: A NEW STEP IN KORIAN INTERNATIONAL EXPANSION REVENUE ( M) Casa Reha Foyer de Lork Medidep Segesta Phönix
More informationRevenue up 6.1% in the third quarter of 2018
PRESS RELEASE Paris, 24 October 2018 Revenue up 6.1% in the third quarter of 2018 Sustained growth in France: 3.6% in the third quarter Strong growth internationally: 8.7% in the third quarter Continued
More information2017 FULL-YEAR RESULTS MARCH 15ᵗʰ, 2018
2017 FULL-YEAR RESULTS MARCH 15ᵗʰ, 2018 2017 KEY HIGHLIGHTS SOLID PERFORMANCE IN LINE WITH OBJECTIVES Revenue up 5% at 3.1bn Dynamic growth internationally +9.7% Balanced mix between organic growth and
More information2018 INTERIM RESULTS SEPTEMBER 13ᵗʰ, 2018
2018 INTERIM RESULTS SEPTEMBER 13ᵗʰ, 2018 H1 2018 KEY ACHIEVEMENTS SOLID PROGRESS ON GROWTH & OPERATIONAL EFFICIENCY TRANSFORMATION MOMENTUM ACCELERATING Acceleration in revenue growth to 6% More dynamic
More information2014 ANNUAL RESULTS PRESENTATION
ANNUAL RESULTS PRESENTATION Paris, 19 March 2015 Delivering Transformation. Together. INTRODUCTION Pierre Pasquier - Chairman 2 AGENDA 1 Introduction 2 Performance in Steria scope Sopra scope Sopra Steria
More informationAnnual revenue of 2,986.8 million (+15.8%) Strong growth driven by international revenue At least 5% revenue growth expected for 2017
PRESS RELEASE Paris, 8 February 2017 Annual revenue of 2,986.8 million (+15.8%) Strong growth driven by international revenue At least 5% revenue growth expected for 2017 Strong growth of 2016 revenue
More informationAegis Group plc Half Year Results. 27 August 2010
Aegis Group plc 2010 Half Year Results 27 August 2010 Agenda Introduction John Napier, Chairman Aegis Group overview Jerry Buhlmann, CEO Divisional review Aegis Media - Jerry Buhlmann, CEO Synovate Robert
More informationPRESENTATION OF 2017 ANNUAL RESULTS
PRESENTATION OF 2017 ANNUAL RESULTS Paris, 19 February 2018 Delivering Transformation. Together. DISCLAIMER This presentation contains forward-looking information subject to certain risks and uncertainties
More informationAegis Group plc. 17 March 2011
Aegis Group plc 2010 Full Year Results 2010 Full Year Results 17 March 2011 Agenda Introduction John Napier, Chairman Aegis Group overview Jerry Buhlmann, CEO Divisional review Aegis Media - Jerry Buhlmann,
More informationAcquisition of Casa Reha
Major step in Korian s expansion in Germany PARIS 10 NOVEMBER 2015 1 Disclaimer 2 Casa Reha: A strategic acquisition Major achievement in Germany Reinforced leadership in the most dynamic European market
More informationAEGIS GROUP PLC 2008 ANNUAL RESULTS. 19 March 2009
AEGIS GROUP PLC 2008 ANNUAL RESULTS 19 March 2009 AGENDA OVERVIEW OF RESULTS John Napier FINANCIAL REVIEW Alicja Lesniak OUTLOOK John Napier Q&A Aegis Group plc Page 2 OVERVIEW OF RESULTS John Napier,
More information2016 HALF-YEAR FINANCIAL REPORT
2016 HALF-YEAR FINANCIAL REPORT CHAPTER 1. Half-year management report 1 1.1. Message from the Chief Executive Officer 2 1. Business in the fir t half of 2016 3 1.3. Consolidated financial tatements 6
More informationA leading provider of post acute services
A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More information2017 NOTICE OF MEETING BROCHURE
2017 NOTICE OF MEETING BROCHURE Combined General Meeting Thursday, 22 June 2017 at 9.00 am Centre Étoile Saint-Honoré 21-25, rue Balzac, 75008 Paris Welcome to the Korian General Meeting Thursday, 22
More informationNedap 2016 annual figures press release
Revenue and operating profit rose in 2016 One-off costs of supply chain reorganisation lower than expected Groenlo, Netherlands, 16 February 2017 Nedap s overall revenue was up 3% in 2016, rising to 186.0
More informationQuarterly statement
www.deutsche-boerse.com Quarterly statement Quarter 1 / 2016 2 Deutsche Börse Group quarterly statement Q1/2016 Q1/2016: Deutsche Börse Group continues growth path Quarterly results at a glance Deutsche
More informationRevenue % Operating profit before non-recurring items EBITA % % of revenue 5.8% 6.6% pt
2017 results Operating profit before non-recurring items (EBITA) (1) up 17.6% to 26.0 million EBITA margin up 0.8 pt to 6.6% Free cash-flow (2) : 20.8 million, representing 5.3% of revenue Dividend (3)
More informationCleopatra Hospitals Group Reports 1Q2017 Results
Cleopatra Hospitals Group Reports 1Q2017 Results 1Q2017 Financial and Operational Highlights 1 EGP 262.1 million Total Consolidated Revenue EGP 61.8 million Adj. EBITDA (24% margin) EGP 29.1 million Net
More informationInterim FY 2015 results 6 months ended 31 December February 2015
Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights
More informationBertelsmann Interim Results 2015
Bertelsmann Interim Results 2015 Investor Conference Call August 31, 2015 Roger Schweitzer, Executive Vice President Corporate Treasury and Finance of Bertelsmann Summary and highlights Interim Results
More information4 th quarter and annual results 2011 strong growth in North America, gradual slowdown in Europe revenue up 13% and diluted earnings per share up 8%
4 th quarter and annual results 2011 strong growth in North America, gradual slowdown in Europe revenue up 13% and diluted earnings per share up 8% Ben Noteboom, CEO Robert-Jan van de Kraats, CFO Randstad
More informationD E E P D I V E INTO F R E N C H R E TA I L G R O W T H D R I V E R S
D E E P D I V E INTO F R E N C H R E TA I L G R O W T H D R I V E R S 2 8. 1 1. 2 0 1 7 Bernardo Sanchez Incera Deputy CEO Philippe Aymerich Head of Credit du Nord PROFESSIONAL CLIENT BASE Laurent Goutard
More informationHalf-Year 2016 results
Half-Year 2016 results 28 September 2016 Agenda 1. Introduction 2. Acquisition of Sanyres and ORPEA Ibérica 3. Network and development 4. Half-Year 2016 results 5. 2016 openings 6. International development
More information2014 REGISTRATION DOCUMENT
2014 REGISTRATION DOCUMENT This Registration Document was filed with the Autorité des Marchés Financiers (French Financial Markets Authority AMF ) on 28 April 2015, in accordance with Article 212-13 of
More informationBertelsmann Interim Results 2016
Bertelsmann Interim Results 2016 Investor Conference Call August 31, 2016 Bernd Hirsch Member of the Executive Board and CFO of Bertelsmann Summary and highlights Interim Results 2016 Group key figures
More informationGoldman Sachs 2012 Leveraged Finance Healthcare Conference MATTHEW WALSH SVP FINANCE & CFO
Goldman Sachs 2012 Leveraged Finance Healthcare Conference MATTHEW WALSH SVP FINANCE & CFO 05.01.2012 Forward Looking Statements This presentation contains both historical and forward-looking statements.
More informationFull Year 2008 Earnings
Full Year 2008 Earnings Olivier Piou, CEO Jacques Tierny, CFO March 19, 2009 www.gemalto.com Disclaimer Forward-Looking Statements This communication contains certain statements that are neither reported
More informationInterim Report JANUARY TO SEPTEMBER 2017
9M Interim Report JANUARY TO SEPTEMBER 2017 KEY FIGURES REVENUES AND EARNINGS in EUR k 2017 2016 ¹ 01.01. 30.09.2017 01.01. 30.09.2016 Change Revenues 163,006 163,935 0.6% Total operating performance 157,068
More informationNeopost Interim Results. October 2005
Neopost 2005 Interim Results October 2005 3 October 2005 Disclaimer Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private
More informationNETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION
NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive network
More informationPRESENTATION OF FIRST-HALF 2017 RESULTS
PRESENTATION OF FIRST-HALF 2017 RESULTS Paris, 28 July 2017 Delivering Transformation. Together. DISCLAIMER This presentation contains forward-looking information subject to certain risks and uncertainties
More informationRegus Group plc Interim Report Six months ended June 2005
Regus Group plc Interim Report Six months ended June 2005 Financial Highlights (a) 216.0m TURNOVER (2004: 124.9m) 48.7m CENTRE CONTRIBUTION (2004: 17.5m) 22.3m ADJUSTED EBITA (b) (2004: 1.9m LOSS) 37.4m
More informationElis 2017 annual results MARCH 7, 2018
Elis 2017 annual results MARCH 7, 2018 Forward looking statements This document may contain information related to the Group s outlook. Such outlook is based on data, assumptions and estimates that the
More information1,633m 2013 Revenues 2013 ANNUAL RESULTS. 13 March ,427 Employees in % of Revenues for International in 2013
1,633m 2013 Revenues 2013 ANNUAL RESULTS 13 March 2014 55% of Revenues for International in 2013 20,427 Employees in 2013 Disclaimer This presentation contains forward-looking statements (as defined in
More information2017 GENERAL MEETING. Gérard Adsuar Chief Financial Officer. 4 May 2017
2017 GENERAL MEETING Gérard Adsuar Chief Financial Officer 4 May 2017 CONTENTS 1 2 3 4 5 KEY FIGURES FOR THE GROUP 2016 PERFORMANCE BY DIVISION 2016 GROUP FINANCIAL RESULTS FINANCIAL POSITION GUIDANCE
More informationA leading provider of post acute services
A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More informationPortfolio acquisitions SEK 3.3 bn. Oct Dec 2013
Year-end Report 2013 Gross cash collections SEK 1.6 bn Portfolio acquisitions SEK 3.3 bn EBIT margin 26% Capital adequacy ratio 11.62% Fourth quarter 2013 Full year 2013 Gross cash collections of SEK 519
More information2018 Half Year Results Presentation. 18 September 2018
2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including
More informationWAVIN GROUP REPORTS STRONG INCREASE IN REVENUE AND OPERATING RESULTS IN FIRST HALF YEAR 2007
WAVIN GROUP REPORTS STRONG INCREASE IN REVENUE AND OPERATING RESULTS IN FIRST HALF YEAR 2007 Zwolle, 6 September 2007 Wavin N.V., leading supplier of plastic pipe systems and solutions in Europe, today
More informationInterim results. September/October 2010
2 0 1 0 Interim results September/October 2010 1 DISCLAIMER Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities
More informationFourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014
Fourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014 Forward Looking Information & Disclosure Certain of the statements contained in this presentation are "forward-looking information
More information1H17 Results 21 July 2017
1H17 Results 21 July 2017 Disclaimer This document has been prepared by NATURHOUSE HEALTH S.A. ( NATURHOUSE or the Company ) for its exclusive use during the presentations announcing the Company s results
More informationBertelsmann Annual Results 2016
Bertelsmann Annual Results Investor Conference Call March 28, 2017 Bernd Hirsch Member of the Executive Board and CFO of Bertelsmann Summary and highlights Financial year Strong operating performance in
More informationInterim Financial Statement, Q1 2006/07 (1 October December 2006)
Stock Exchange Announcement no. 1/2007 8 February, 2007 Interim Financial Statement, Q1 2006/07 (1 October 2006-31 December 2006) "We are pleased with Coloplast s performance," says Sten Scheibye, President
More informationFirst Half 2007 Management Report
First Half 2007 Management Report H1 2007 key figures in millions of euros H1 2006 H1 2007 07/06 as published 07/06 ex.currency Total revenue 5,483 5,629 +2.7% +6.3%* Operating income recurring 807 856
More informationManagement s Discussion & Analysis
Management s Discussion & Analysis For the three and six month interim period ended June 30, Medworxx Solutions Inc. 700 121 Richmond St W. Toronto, ON M5H 2K1 This Management s Discussion and Analysis
More informationFull year report January December 2017
Capio AB (publ) Full year report January December 2017 October December 2017 Net sales MSEK 4,077 (3,725). Organic sales growth 3.4% (2.9) and total sales growth 9.4% (6.1) EBITDA 1 MSEK 348 (289) and
More informationEnel: the Board approves 2004 results
Enel: the Board approves 2004 results Revenues 36,489 million euro (31,317 million euro in 2003, +16.5%) EBITDA 11,010 million euro (9,841 million euro in 2003, +11.9%) EBIT 6,325 million euro (4,732 million
More informationQ Results: Europcar starts the year with accelerating revenue growth, in line with the Group s strategic ambitions
Note: this press release includes non-audited consolidated results under IFRS, as approved by the management board and reviewed by the supervisory board on May 14 th 2018 Q1 2018 Results: Europcar starts
More informationSKYCITY Entertainment Group Limited 2008 Full Year Result Presentation
SKYCITY Entertainment Group Limited 2008 Full Year Result Presentation Agenda I. Highlights and Result Summary 3 II. Business Unit Results 10 III. Financial Results 23 IV. Strategy and Outlook 30 V Appendix
More informationGrowth, performance and roll-out of the strategy
Bezannes, 20 September 2018 8.00 am 2018 half-year results Growth, performance and roll-out of the strategy International development: acquisition of a prime asset in Spain Successful capital increase:
More informationDividend unchanged at 1.65 euro per share. Battle plan to face a difficult environment
Press Release Paris February 25, 2009 Profit before tax 1 on target, at 875 million Dividend unchanged at 1.65 euro per share Battle plan to face a difficult environment Accor is staying on course and
More informationCHIEF FINANCIAL OFFICER S REVIEW
15 CHIEF FINANCIAL OFFICER S REVIEW Capita has early adopted IFRS 15, the new revenue recognition standard, and this report on our performance in 2017 against the comparative period in 2016 is under the
More informationThomas Cook Group. Interim Results 6 months ended 31 March May 2010
Thomas Cook Group Interim Results 6 months ended 31 March 2010 13 May 2010 Welcome and Introduction Agenda 1 Key Highlights Manny Fontenla-Novoa 2 Financial Review Paul Hollingworth 3 Current Trading and
More informationAsterand plc. Interim Results for the Period Ended 30 June 2006
For further information, please contact Asterand plc Randal Charlton, CEO Ronald Openshaw, CFO Tel: +44(0) 1763 211600 www.asterand.com Financial Dynamics David Yates Sarah MacLeod Tel: +44(0) 20 7831
More informationFor personal use only
Preliminary Final Report Appendix 4E Results for announcement to the market Pulse Health Limited (ACN 104 113 760) This Preliminary Final Report is provided to the Australian Securities Exchange (ASX)
More informationFinancial results & business update. Quarter and year ended 31 December February 2016
Financial results & business update Quarter and year ended 31 December 2015 11 February 2016 Disclaimer 3 Any remarks that we may make about future expectations, plans and prospects for the company constitute
More informationFinancial results & business update. Quarter and year ended 31 December February 2017
Financial results & business update Quarter and year ended 31 December 2016 14 February 2017 Disclaimer 3 Any remarks that we may make about future expectations, plans and prospects for the company constitute
More informationi n f o r m a t i o n
i n f o r m a t i o n Press Release Paris, February 27, 2007 A new year of growth in 2006 Net profit of 1 billion +11.4% comparable Five-year ambition raised The Board of Directors of Air Liquide chaired
More information2017 Full Year Results. Tuesday 21 November 2017
2017 Full Year Results Tuesday 21 November 2017 Disclaimer Certain information included in the following presentation is forward looking and involves risks, assumptions and uncertainties that could cause
More informationPRELIMINARY RESULTS 2014 FOR THE YEAR ENDING 31st DECEMBER Tuesday 3rd March 2015
PRELIMINARY RESULTS 2014 FOR THE YEAR ENDING 31st DECEMBER 2014 Tuesday 3rd March 2015 PRELIMINARY RESULTS 2014 HIGHLIGHTS Strong organic revenue growth of 6% Underlying PBT increased by 3% Established
More informationK E N D R I O N N. V. P R E S S R E L E A S E. 1 9 F e b r u a r y
K E N D R I O N N. V. P R E S S R E L E A S E 1 9 F e b r u a r y 2 0 1 9 KENDRION MAINTAINS PROFITABILITY FOR THE YEAR DESPITE DIFFICULT AUTOMOTIVE MARKET - Full-year revenue declined by 3% to EUR 448.6
More informationGenesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015
Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare
More informationGENERAL MEETING 3 MAY Arnaud Lagardère General and Managing Partner
GENERAL MEETING 3 MAY 2018 Arnaud Lagardère General and Managing Partner CONTENTS 1 OUR MARKETS AND THEIR TRENDS 2 OUR GROUP TODAY 3 OUR STRATEGIC VISION AND AMBITION 2 OUR MARKETS AND OUR GROUP TODAY
More information2016 FULL-YEAR RESULTS Wednesday, March 15 th 2017
2016 FULL-YEAR RESULTS Wednesday, March 15 th 2017 FORWARD LOOKING STATEMENTS This presentation may contain some forward-looking statements. These statements are not undertakings as to the future performance
More informationFY 2016 Results Presentation. 8 March, 2017
FY 2016 Results Presentation 8 March, 2017 Today s presenters Prasanth Manghat Chief Executive Officer CEO since March 2017 20 years of experience including 12 years at NMCrelated businesses with 5 years
More informationQ Strong start for Kimmo Alkio, President and CEO Lasse Heinonen, CFO Tanja Lounevirta, Head of IR. 26 April 2018.
Public Q1 218 Strong start for 218 Kimmo Alkio, President and CEO Lasse Heinonen, CFO Tanja Lounevirta, Head of IR 26 April 218 Q1 218 in brief Strong start for 218 Growth in local currencies 6%, organically
More information2018 Half-Year Results
2018 Half-Year Results 26 September 2018 Agenda 1. ORPEA Quality and innovation policy 2. Network and development 3. 2018 half-year results 4. Openings in 2018 5. Strategy and outlook Appendix 2 Comprehensive
More informationInterim Financial Report as at 31 March 2018
Interim Financial Report as at 31 March 2018 Interim Report as at 31 March 2018 TRANSLATION FROM THE ORIGINAL ITALIAN TEXT INDEX PREFACE... 4 INTERIM MANAGEMENT REPORT AS AT 31 MARCH 2018... 5 CHANGES
More informationFor personal use only
ASX Announcement Slater and Gordon Group FY16 Half Year Financial Results Results Summary H1 FY16 H1 FY15 Total Revenue 487.5 267.7 EBITDAW (1) (58.3) 61.5 EBITDAW (1,2) Normalised (17.8) 32.6 Goodwill
More informationSTRATEGY PAYING OFF; REVENUE UP 10%, EBITA UP 28%
STRATEGY PAYING OFF; REVENUE UP 10%, EBITA UP 28% THIRD-QUARTER 2015 RESULTS Almere, 30 October 2015 THIRD-QUARTER 2015 HIGHLIGHTS Revenue rose 9.7% to 684.1 million (Q3 2014: 623.8 million); revenue in
More informationPRESS RELEASE. Sales came to million in 2009, down 0.5% compared with 2008, or down 0.3% at constant exchange rates.
2009: A ROBUST PERFORMANCE IN A PARTICULARLY CHALLENGING ENVIRONMENT Current operating margin1 maintained at 25.7% of sales 2009 dividend: 3.80 euros per share Full-year sales virtually unchanged: -0.3%
More informationPress release February 28, FULL-YEAR 2017 RESULTS Recurring Operating Income of 2.0bn Free cash flow (excluding exceptional items) of 950m
FULL-YEAR 2017 RESULTS Recurring Operating Income of 2.0bn Free cash flow (excluding exceptional items) of 950m Slowdown in Group like-for-like sales, at +1.6% in 2017 vs. +3.0% in 2016. Recurring Operating
More informationFor personal use only
ASX ANNOUNCEMENT 23 August 2012 RAMSAY HEALTH CARE REPORTS 14.5% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 up 14.5% to $252.6 million Reported statutory net profit after
More informationFor personal use only
Appendix 4D Results for announcement to the market (ACN 104 113 760) This half-year report is provided to the Australian Securities Exchange (ASX) under ASX listing Rule 4.2A.3. Current reporting period:
More informationExcellent results for Alstom in the first half 2018/19
PRESS RELEASE Excellent results for Alstom in the first half 2018/19 Strong commercial momentum with 7 billion orders, leading to a new record-breaking backlog of 38 billion Outstanding operational performance
More informationQ Strong growth solid profitability Kimmo Alkio, President and CEO Janne Salminen, Acting CFO Tanja Lounevirta, Head of IR
Public Q3 218 Strong growth solid profitability Kimmo Alkio, President and CEO Janne Salminen, Acting CFO Tanja Lounevirta, Head of IR Q3 218 in brief Strong growth solid profitability Growth in local
More informationDOCDATA N.V. realises a strong first half-year and also expects growth of revenue and profit for the full-year 2013
To be distributed on Thursday 18 July 2013 Continental Time 07.30h. U.K. 06.30h. / U.S. Eastern Standard Time 01.30h. DOCDATA N.V. realises a strong first half-year and also expects growth of revenue and
More informationInterim Report Q Self Storage Group ASA
Interim Report Q2 2018 Self Storage Group ASA Contents Highlights 2 Key Figures 2 Subsequent events 2 Financial development 3 Strategy 6 Corporate developments 8 Risks and uncertainty factors 8 Outlook
More informationA leading provider of post acute services
A leading provider of post acute services September 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More informationREZIDOR HOTEL GROUP AB (PUBL.)
REZIDOR HOTEL GROUP AB (PUBL.) YEAR END FINANCIAL REPORT 1 ST JANUARY 31 ST DECEMBER Full year Revenue increased to MEUR 707.3 (587.0). Profit after tax of MEUR 29.0 (23.2) Earnings Per Share amounts to
More informationTRAVIS PERKINS PLC RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011
TRAVIS PERKINS PLC RESULTS FOR THE YEAR ENDED 31 DECEMBER 2011 CONTINUED ROBUST PERFORMANCE ON MARKET SHARE GAINS, MARGINS, EARNINGS AND CASH GENERATION FINANCIAL HIGHLIGHTS DIVIDEND UP 33% Group revenue
More information2017 GENERAL MEETING. Arnaud Lagardère General and Managing Partner. 4 May 2017
2017 GENERAL MEETING Arnaud Lagardère General and Managing Partner 4 May 2017 CONTENTS 1 2 3 4 OUR MARKETS AND TRENDS OUR GROUP TODAY OUR VALUE CREATION STRATEGY OUR PERFORMANCE 5 OUR OUTLOOK 2 OUR MARKETS
More informationInterim Report H1/2018
Interim Report H1/2018 Columbus A/S CVR.: 13 22 83 45 Columbus, Lautrupvang 6, DK-2750 Ballerup Phone: +45 70 20 50 00, Fax: +45 70 25 07 01 www.columbusglobal.com, CVR.: 13 22 83 45 2 Financial Statements
More informationInterim Report 1 st Half The Quality Connection The Quality Connection
Interim Report 1 st Half 2016 The Quality Connection The Quality Connection Highlights 1 st Half 2016 Consolidated sales come to 2.24 billion and thus nearly the previous year s level EBIT of 61.9 million
More informationFor personal use only. JB Hi-Fi Limited. HY18 Results Presentation
JB Hi-Fi Limited HY8 Results Presentation 5 FEBRUARY AUGUST 06 08 PAGE Agenda. Group Performance Overview. JB HI-FI 3. The Good Guys 4. Group Balance Sheet and Cash Flow 5. Outlook Richard Murray Group
More informationAxway Software Half-Year 2018: Revenue 1 of million and Operating margin of 9.1%
Contacts Investor Relations: Arthur Carli +33 (0)1 47 17 24 65 acarli@axway.com Press Relations: Sylvie Podetti +33 (0)1 47 17 22 40 spodetti@axway.com Press Release Axway Software Half-Year 2018: Revenue
More informationINFORMATION ON THE MANAGEMENT BOARD S COMPENSATION FOR FINANCIAL YEAR 2018 AND 2019
INFORMATION ON THE MANAGEMENT BOARD S COMPENSATION FOR FINANCIAL YEAR 2018 AND 2019 In accordance with the AFEP-MEDEF Corporate Governance Code regarding the publication of the compensation of executive
More informationForward Looking Statements
Forward Looking Statements Certain statements in this presentation constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements
More informationInterim financial report for the six-month period ended 30 June 2016
Interim financial report for the six-month period ended 30 June 2016 1 2 3 4 Summary HALF-YEAR 3 Key events in the first half of 2016 4 Business performance in the first half of 2016 5 Results for the
More informationINTERIM CONSOLIDATED CONDENSED FINANCIAL STATEMENTS FOR THE FINANCIAL QUARTER ENDED 31 MARCH 2017
INTERIM CONSOLIDATED CONDENSED FINANCIAL STATEMENTS FOR THE FINANCIAL QUARTER ENDED 31 MARCH 2017 Consolidated statement of financial position Assets ( millions) Notes 31.03.2017 31.12.2016 Non-current
More informationINTERIM FINANCIAL REPORT First quarter 2018 Company announcement no. 690
INTERIM FINANCIAL REPORT First quarter 2018 Company announcement no. 690 1 May 2018 Selected financial and operating data for the period 1 January 31 March 2018 (DKKm) Q1 2018 Q1 2017 Net revenue 18,380
More informationDS Smith Plc. Full Year Results 2010/11 23 June 2011
DS Smith Plc Full Year Results 2010/11 23 June 2011 Introduction Miles Roberts Group Chief Executive 2 Strong performance, more to go for Packaging volume up 8% EBITA up 39% to 136.1m, 20% excluding Otor
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More informationNordic develops well while France improves in a weak market and Germany is under restructuring.
Capio AB (publ) Interim report Jan Sep 2018 July September 2018 Net sales MSEK 3,816 (3,455). Organic sales growth 2.1% (2.2) and total sales growth 10.4% (9.1) EBITDA 1 MSEK 189 (168) and margin 5.0%
More information